NAGSTATIN;8-(ACETYLAMINO)-5,6,7,8-TETRAHYDRO-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-IMIDAZO-[1,2-A]-PYRIDINE-2-ACETIC-ACID
Compound with spectra: 1 NMR
![NAGSTATIN;8-(ACETYLAMINO)-5,6,7,8-TETRAHYDRO-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-IMIDAZO-[1,2-A]-PYRIDINE-2-ACETIC-ACID](/api/compound/EajDYwJJMqs.png?ph=true&h=300&w=458 "NAGSTATIN;8-(ACETYLAMINO)-5,6,7,8-TETRAHYDRO-6,7-DIHYDROXY-5-(HYDROXYMETHYL)-IMIDAZO-[1,2-A]-PYRIDINE-2-ACETIC-ACID")
| SpectraBase Compound ID | EajDYwJJMqs |
|---|---|
| InChI | InChI=1S/C12H17N3O6/c1-5(17)13-9-11(21)10(20)7(4-16)15-3-6(2-8(18)19)14-12(9)15/h3,7,9-11,16,20-21H,2,4H2,1H3,(H,13,17)(H,18,19)/t7-,9-,10+,11-/m0/s1 |
| InChIKey | XPJWMTPRJTUTBX-BBHBSTQDSA-N |
| Mol Weight | 299.28 g/mol |
| Molecular Formula | C12H17N3O6 |
| Exact Mass | 299.111735 g/mol |
| Enantiomer InChIKey | XPJWMTPRJTUTBX-CZULRBLNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
Coumarin 337
6-amino-4-[4-methoxy-3-(methoxymethyl)phenyl]-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
No Name
Ethyl 2-(Bromomethyl)-4-ethoxy-2,5-dihydro-2-(4-nitrophenyl)-5-oxofuran-3-carboxylate
3-TRIFLUOROACETAMIDOPROPYL 2-ACETAMIDO-2-DEOXY-4-O-(2,3,4-TRI-O-BENZYL-ALPHA-L-FUCOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidin-6(7H)-one, 7-butyl-2-(3-pyridinyl)-
Tetraethyl 5,6-bis(bromomethyl)tetraline-2,2,3,3-tetracarboxylate
5-[(2,4-dimethylanilino)-oxomethyl]-2-[[(2-methoxyphenyl)-oxomethyl]amino]-4-methyl-3-thiophenecarboxylic acid ethyl ester
Androstan-17-ol, 2,3-epithio-, (2.alpha.,3.alpha.,5.alpha.,17.beta.)-
6,8-DIPRENYLERIODICTYOL;6,8-DIPRENYL-5,7,3',4'-TETRAHYDROXYFLAVANONE
| Title | Journal or Book | Year |
|---|---|---|
| The structure of nagstatin, a new inhibitor of N-acetyl-.BETA.-D-glucosaminidase. | The Journal of Antibiotics | 1992 |